Short-term hemodynamic effect of angiotensin-converting enzyme inhibition in patients with severe aortic stenosis: A placebo-controlled, randomized study

American Heart Journal

Volumn 167, Issue 2, 2014, Pages 226-234

  Dalsgaard, Morten ^a   Iversen, Kasper ^b   Kjaergaard, Jesper ^a   Grande, Peer ^a   Goetze, Jens Peter ^a   Clemmensen, Peter ^a   Hassager, Christian ^a  

^a University of Copenhagen   (Denmark)

^b HILLERØD HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; PLACEBO; TRANDOLAPRIL;

ADULT; AGED; AORTA STENOSIS; AORTA VALVE; AORTA VALVE REPLACEMENT; ARTERY COMPLIANCE; ARTICLE; BRAIN ISCHEMIA; CARDIOPULMONARY EXERCISE TEST; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DOSE ESCALATION; ECHOCARDIOGRAPHY; ENZYME INHIBITION; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART STROKE VOLUME; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE;

AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; AORTIC VALVE STENOSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HEMODYNAMICS; HUMANS; INDOLES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 84892823006     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2013.11.002     Document Type: Article

References (25)

1. B.F. Stewart, D. Siscovick, and B.K. Lind et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study J Am Coll Cardiol 29 1997 630 634
2. S. Helske, K.A. Lindstedt, and M. Laine et al. Induction of local angiotensin II-producing systems in stenotic aortic valves J Am Coll Cardiol 44 2004 1859 1866
3. E.O. Weinberg, F.J. Schoen, and D. George et al. Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis Circulation 90 1994 1410 1422
4. J. Fielitz, S. Hein, and V. Mitrovic et al. Activation of the cardiac renin-angiotensin system and increased myocardial collagen expression in human aortic valve disease J Am Coll Cardiol 37 2001 1443 1449
5. K. Arishiro, M. Hoshiga, and N. Negoro et al. Angiotensin receptor-1 blocker inhibits atherosclerotic changes and endothelial disruption of the aortic valve in hypercholesterolemic rabbits J Am Coll Cardiol 49 2007 1482 1489
6. K.D. O'Brien, J.L. Probstfield, and M.T. Caulfield et al. Angiotensin-converting enzyme inhibitors and change in aortic valve calcium Arch Intern Med 165 2005 858 862
7. M. Dalsgaard, J. Kjaergaard, and R. Pecini et al. Predictors of exercise capacity and symptoms in severe aortic stenosis Eur J Echocardiogr 11 2010 482 487
8. M. Dalsgaard, J. Kjaergaard, and R. Pecini et al. Left ventricular filling pressure estimation at rest and during exercise in patients with severe aortic valve stenosis: comparison of echocardiographic and invasive measurements J Am Soc Echocardiogr 22 2009 343 349
9. P.J. Currie, J.B. Seward, and G.S. Reeder et al. Continuous-wave Doppler echocardiographic assessment of severity of calcific aortic stenosis: a simultaneous Doppler-catheter correlative study in 100 adult patients Circulation 71 1985 1162 1169
10. R.O. Bonow, B.A. Carabello, and C. Kanu et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons Circulation 114 2006 e84 e231
11. M. Briand, J.G. Dumesnil, and L. Kadem et al. Reduced systemic arterial compliance impacts significantly on left ventricular afterload and function in aortic stenosis: implications for diagnosis and treatment J Am Coll Cardiol 46 2005 291 298
12. Z. Hachicha, J.G. Dumesnil, and P. Pibarot Usefulness of the valvuloarterial impedance to predict adverse outcome in asymptomatic aortic stenosis J Am Coll Cardiol 54 2009 1003 1011
13. A. Vahanian, H. Baumgartner, and J. Bax et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology Eur Heart J 28 2007 230 268
14. J. Jimenez-Candil, J. Bermejo, and R. Yotti et al. Effects of angiotensin converting enzyme inhibitors in hypertensive patients with aortic valve stenosis: a drug withdrawal study Heart 91 2005 1311 1318
15. U.N. Khot, G.M. Novaro, and Z.B. Popovic et al. Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis N Engl J Med 348 2003 1756 1763
16. F. Weidemann, S. Herrmann, and S. Stork et al. Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis Circulation 120 2009 577 584
17. I.L. Gerber, R.A. Stewart, and M.E. Legget et al. Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis Circulation 107 2003 1884 1890
18. I.L. Gerber, M.E. Legget, and T.M. West et al. Usefulness of serial measurement of N-terminal pro-brain natriuretic peptide plasma levels in asymptomatic patients with aortic stenosis to predict symptomatic deterioration Am J Cardiol 95 2005 898 901
19. J. Bergler-Klein, U. Klaar, and M. Heger et al. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis Circulation 109 2004 2302 2308
20. A. Chockalingam, S. Venkatesan, and T. Subramaniam et al. Safety and efficacy of angiotensin-converting enzyme inhibitors in symptomatic severe aortic stenosis: Symptomatic Cardiac Obstruction-Pilot Study of Enalapril in Aortic Stenosis (SCOPE-AS) Am Heart J 147 2004 E19
21. S.L. Archer, D.K. Mike, and M.B. Hetland et al. Usefulness of mean aortic valve gradient and left ventricular diastolic filling pattern for distinguishing symptomatic from asymptomatic patients Am J Cardiol 73 1994 275 281
22. O.M. Hess, B. Villari, and H.P. Krayenbuehl Diastolic dysfunction in aortic stenosis Circulation 87 1993 IV73 IV76
23. C.G. Brilla, R.C. Funck, and H. Rupp Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease Circulation 102 2000 1388 1393
24. R. Rosenhek, F. Rader, and N. Loho et al. Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis Circulation 110 2004 1291 1295
25. C.A. Gaillard, and P.W. de Leeuw Clinical experiences with trandolapril Am Heart J 125 1993 1542 1546